| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |